Application

ZELRAYMI

Genzyme Corporation

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90531821
Filing Date: 02/17/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90531821
MARK INFORMATION
*MARK ZELRAYMI
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT ZELRAYMI
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Genzyme Corporation
*MAILING ADDRESS 50 Binney Street
*CITY Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02142
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Massachusetts
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
SIGNIFICANCE OF MARK ZELRAYMI appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the goods/services listed in the application, or any geographical significance.
ATTORNEY INFORMATION
NAME Karen Lim
ATTORNEY DOCKET NUMBER GENZ 2102761
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Fross Zelnick Lehrman & Zissu, P.C.
STREET 151 West 42nd St., 17th Fl.
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10036
EMAIL ADDRESS klim-docket@fzlz.com
OTHER APPOINTED ATTORNEY Lawrence E. Apolzon, Andrew N. Fredbeck, Allison Strickland Ricketts, Nancy Sabarra, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger
CORRESPONDENCE INFORMATION
NAME Karen Lim
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /caroline casalonga/
SIGNATORY'S NAME CASALONGA Caroline
SIGNATORY'S POSITION Authorized Signatory pursuant to a Power of Attorney
DATE SIGNED 02/17/2021
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 90531821
Filing Date: 02/17/2021

To the Commissioner for Trademarks:

MARK: ZELRAYMI (Standard Characters, see mark)
The literal element of the mark consists of ZELRAYMI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Genzyme Corporation, a corporation of Massachusetts, having an address of
      50 Binney Street
      Cambridge, Massachusetts 02142
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Significance of wording, letter(s), or numeral(s)
ZELRAYMI appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the goods/services listed in the application, or any geographical significance.


The owner's/holder's proposed attorney information: Karen Lim. Other appointed attorneys are Lawrence E. Apolzon, Andrew N. Fredbeck, Allison Strickland Ricketts, Nancy Sabarra, Charles T.J. Weigell, Ashford Tucker, Tamar Niv Bessinger. Karen Lim of Fross Zelnick Lehrman & Zissu, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      151 West 42nd St., 17th Fl.
      New York, New York 10036
      United States
      klim-docket@fzlz.com
The docket/reference number is GENZ 2102761.
Karen Lim submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Karen Lim
       PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /caroline casalonga/   Date: 02/17/2021
Signatory's Name: CASALONGA Caroline
Signatory's Position: Authorized Signatory pursuant to a Power of Attorney
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90531821
Payment Accounting Date: 02/17/2021

Serial Number: 90531821
Internet Transmission Date: Wed Feb 17 11:53:32 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2021021711533229
5248-90531821-770969b6b91ec2cf07d8c559cd
6668b16ac6306a44a12c5e16dc6ac14f82a1816-
DA-53323566-20210216150000436104

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed